JP2022517216A5 - - Google Patents
Info
- Publication number
- JP2022517216A5 JP2022517216A5 JP2021540076A JP2021540076A JP2022517216A5 JP 2022517216 A5 JP2022517216 A5 JP 2022517216A5 JP 2021540076 A JP2021540076 A JP 2021540076A JP 2021540076 A JP2021540076 A JP 2021540076A JP 2022517216 A5 JP2022517216 A5 JP 2022517216A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- amino acid
- fragment
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910022548.9 | 2019-01-10 | ||
| CN201910022548.9A CN111423510B (zh) | 2019-01-10 | 2019-01-10 | 重组抗人pd-1抗体及其应用 |
| PCT/CN2020/071353 WO2020143749A1 (zh) | 2019-01-10 | 2020-01-10 | 重组抗人pd-1抗体及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022517216A JP2022517216A (ja) | 2022-03-07 |
| JP2022517216A5 true JP2022517216A5 (cg-RX-API-DMAC7.html) | 2023-01-20 |
Family
ID=71521975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540076A Pending JP2022517216A (ja) | 2019-01-10 | 2020-01-10 | 組換え抗ヒトpd-1抗体およびその用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230104769A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3919514A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022517216A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210113635A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111423510B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3126302A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202043271A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020143749A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022012428A1 (zh) * | 2020-07-14 | 2022-01-20 | 迈威(上海)生物科技股份有限公司 | 抗pd-1抗体及其稳定制剂 |
| US20250270320A1 (en) * | 2020-12-10 | 2025-08-28 | Eutilex Co., Ltd. | Anti-pd-1 antibody and uses thereof |
| CN114907478A (zh) * | 2021-02-08 | 2022-08-16 | 迈威(上海)生物科技股份有限公司 | 结合lag-3的抗体及其用途 |
| CN115925954A (zh) * | 2022-12-28 | 2023-04-07 | 广州誉衡生物科技有限公司 | 抗-pd-1抗体及其在制备治疗尿路上皮癌患者的药物中的用途 |
| WO2025102227A1 (zh) * | 2023-11-14 | 2025-05-22 | 成都盛世君联生物技术有限公司 | 一种抗pd-1抗体及其生物材料和产品 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60334303D1 (de) | 2002-07-03 | 2010-11-04 | Tasuku Honjo | Immunpotenzierende zusammensetzungen |
| EP3530736A3 (en) | 2005-05-09 | 2019-11-06 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| PT2170959E (pt) | 2007-06-18 | 2014-01-07 | Merck Sharp & Dohme | Anticorpos para o receptor humano de morte programada pd-1 |
| AU2009290544B2 (en) | 2008-09-12 | 2015-07-16 | Oxford University Innovation Limited | PD-1 specific antibodies and uses thereof |
| CA2833636A1 (en) | 2011-04-20 | 2012-10-26 | Amplimmune, Inc. | Antibodies and other molecules that bind b7-h1 and pd-1 |
| CN104250302B (zh) | 2013-06-26 | 2017-11-14 | 上海君实生物医药科技股份有限公司 | 抗pd‑1抗体及其应用 |
| SMT202300039T1 (it) | 2013-09-13 | 2023-03-17 | Beigene Switzerland Gmbh | Anticorpi anti-pd1 e loro uso come terapia e per diagnostica |
| CR20160319A (es) | 2013-12-12 | 2016-11-08 | Jiangsu Hengrui Medicine Co | Anticuerpo pd-1, fragmento de union al antigeno de este y uso médico de este |
| KR102524920B1 (ko) * | 2014-07-22 | 2023-04-25 | 아폴로믹스 인코포레이티드 | 항-pd-1 항체 |
| CN105330740B (zh) | 2014-07-30 | 2018-08-17 | 珠海市丽珠单抗生物技术有限公司 | 抗pd-1抗体及其应用 |
| PE20231958A1 (es) * | 2015-07-30 | 2023-12-06 | Macrogenics Inc | Moleculas de union a pd-1 y metodos de uso de las mismas |
| WO2017024465A1 (en) | 2015-08-10 | 2017-02-16 | Innovent Biologics (Suzhou) Co., Ltd. | Pd-1 antibodies |
| RU2722451C1 (ru) * | 2015-09-29 | 2020-06-01 | Шанхай Чжанцзян Биотекнолоджи Ко., Лтд. | Pd-1 антитела и их применение. |
| CN106632674B (zh) * | 2015-10-30 | 2018-11-16 | 泽达生物医药有限公司 | 一种抗pd-1单克隆抗体、其药物组合物及其用途 |
| CN106699889A (zh) * | 2015-11-18 | 2017-05-24 | 礼进生物医药科技(上海)有限公司 | 抗pd-1抗体及其治疗用途 |
| CN109152798B (zh) * | 2015-12-02 | 2022-10-21 | 斯特库比股份有限公司 | 特异于糖基化的pd-1的抗体及其使用方法 |
| CN108079292A (zh) * | 2016-11-23 | 2018-05-29 | 苏州盛迪亚生物医药有限公司 | 一种抗pd-1抗体在制备治疗肝癌的药物中的用途 |
| CN107446048B (zh) * | 2017-09-13 | 2021-03-30 | 北京韩美药品有限公司 | 一种能够特异性地结合pd-1的抗体及其功能片段 |
| CN108218988B (zh) * | 2017-11-29 | 2019-10-11 | 广西医科大学 | 抗PD-1的纳米抗体PD-1/Nb52及其制备方法与应用 |
| CN108727504B (zh) * | 2018-04-16 | 2021-08-27 | 泉州向日葵生物科技有限公司 | 一种ifn与抗pd-l1抗体的融合蛋白及其应用 |
| CA3143034A1 (en) * | 2019-06-14 | 2020-12-17 | Cugene Inc. | Novel interleukin-2 variants for the treatment of cancer |
| KR20220114063A (ko) * | 2019-12-13 | 2022-08-17 | 큐진 인크. | 신규한 인터루킨-15 (il-15) 융합 단백질 및 이의 용도 |
| AU2020403148A1 (en) * | 2019-12-13 | 2022-06-30 | Cugene Inc. | Cytokine-based bioactivatable drugs and methods of uses thereof |
-
2019
- 2019-01-10 CN CN201910022548.9A patent/CN111423510B/zh active Active
-
2020
- 2020-01-09 TW TW109100705A patent/TW202043271A/zh unknown
- 2020-01-10 JP JP2021540076A patent/JP2022517216A/ja active Pending
- 2020-01-10 EP EP20738344.9A patent/EP3919514A4/en not_active Withdrawn
- 2020-01-10 CA CA3126302A patent/CA3126302A1/en active Pending
- 2020-01-10 KR KR1020217024728A patent/KR20210113635A/ko not_active Ceased
- 2020-01-10 US US17/422,123 patent/US20230104769A1/en not_active Abandoned
- 2020-01-10 WO PCT/CN2020/071353 patent/WO2020143749A1/zh not_active Ceased